Source: Pharmaceutical Business Review

BDR: Procaps Group and BDR sign agreement for oncology molecules

As per the agreement, Procaps will be responsible for activities related to registration, branding, marketing along with commercialisation throughout Latin America. Procaps submitted an initial set of eight The post Procaps Group and BDR sign agreement for oncology molecules appeared first on Pharmaceutical Business review.

Read full article »
Est. Annual Revenue
$100-500M
Est. Employees
100-250
Dharmesh Shah's photo - Managing Director of BDR

Managing Director

Dharmesh Shah

CEO Approval Rating

90/100

Read more